GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Delivra Health Brands Inc (OTCPK:DHBUF) » Definitions » Research & Development

Delivra Health Brands (Delivra Health Brands) Research & Development : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Delivra Health Brands Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Delivra Health Brands's Research & Development for the three months ended in Mar. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

Delivra Health Brands Research & Development Historical Data

The historical data trend for Delivra Health Brands's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delivra Health Brands Research & Development Chart

Delivra Health Brands Annual Data
Trend Dec14 Dec15 Dec16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.13 0.06 - -

Delivra Health Brands Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Delivra Health Brands Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delivra Health Brands  (OTCPK:DHBUF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Delivra Health Brands Research & Development Related Terms

Thank you for viewing the detailed overview of Delivra Health Brands's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Delivra Health Brands (Delivra Health Brands) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Delivra Health Brands Inc (OTCPK:DHBUF) » Definitions » Research & Development
Comparable Companies
XCNQ:AION XCNQ:LOWL XCNQ:HERB XCNQ:LOBE XCNQ:VIBE XCNQ:BCBC XCNQ:THC XCNQ:BBM TSXV:HMPG XCNQ:AYUR ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
U01:Germany DHB:Canada
Address
999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2
Website
https://www.delivrahealthbrands.com
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.